360 High-Risk Vulnerability Immunization Tool V2.0 vs Kaseya 365 Endpoint: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Kaseya 365 Endpoint: Unified endpoint mgmt platform with RMM, EDR, AV, backup & patch mgmt. built by Kaseya. Core capabilities include Remote monitoring and management (RMM), Endpoint detection and response (EDR), Antivirus protection..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Kaseya 365 Endpoint differentiates with Remote monitoring and management (RMM), Endpoint detection and response (EDR), Antivirus protection.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Kaseya 365 Endpoint is developed by Kaseya. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Kaseya 365 Endpoint serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Patch Management. Review the feature comparison above to determine which fits your requirements.